It was speculated that the therapeutic effect of FRB on NAFLD was inconsistent with past studies, which might have been due to the age of the animals, the fat composition in the HF diet, bacterial species used for fermentation, or the feeding period. This evidence concerns the gene FOLR2 and metabolic dysfunction-associated steatotic liver disease.